Effect of COVID-19 on Anakinra-induced Remission in Homozygous STX11 Hemophagocytosis Lymphohistiocytosis

Overview

Journal Pediatr Blood Cancer

Specialties Hematology
Oncology
Pediatrics

Date 2021 Jan 14

PMID 33442938

Citations 6

Authors

Anshul Vagrecha

Hiren B Patel

Tania Mamdouhi

Suchitra Acharya

Abena Appiah-Kubi

Banu Aygun

Adrianna Vlachos

Lawrence C Wolfe

Jeffrey M Lipton

Randy Q Cron

Carolyn Fein Levy

Affiliations

Soon will be listed here.

Citing Articles

Integrative network analysis identifies pivotal host genes and pathways for SARS-CoV-2 infection.

Chen G, Li L, Wang R, Liu B, Cao Z, Zhao N Genes Dis. 2024; 12(1):101206.

PMID: 39386106 PMC: 11462195. DOI: 10.1016/j.gendis.2024.101206.

Salvage Therapy and Allogeneic Hematopoietic Cell Transplantation for the Severe Cytokine Storm Syndrome of Hemophagocytic Lymphohistiocytosis.

Marsh R Adv Exp Med Biol. 2024; 1448:611-622.

PMID: 39117843 DOI: 10.1007/978-3-031-59815-9_41.

IL-1 Family Blockade in Cytokine Storm Syndromes.

Cron R Adv Exp Med Biol. 2024; 1448:553-563.

PMID: 39117838 DOI: 10.1007/978-3-031-59815-9_36.

Rare genetic variants involved in multisystem inflammatory syndrome in children: a multicenter Brazilian cohort study.

Dos Reis B, Faccion R, de Carvalho F, Moore D, Zuma M, Placa D Front Cell Infect Microbiol. 2023; 13:1182257.

PMID: 37588055 PMC: 10426286. DOI: 10.3389/fcimb.2023.1182257.

Hemophagocytic Lymphohistiocytosis Gene Variants in Multisystem Inflammatory Syndrome in Children.

Vagrecha A, Zhang M, Acharya S, Lozinsky S, Singer A, Levine C Biology (Basel). 2022; 11(3).

PMID: 35336791 PMC: 8945334. DOI: 10.3390/biology11030417.

References

Locatelli F, Jordan M, Allen C, Cesaro S, Rizzari C, Rao A . Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis. N Engl J Med. 2020; 382(19):1811-1822. DOI: 10.1056/NEJMoa1911326. View

Henderson L, Canna S, Friedman K, Gorelik M, Lapidus S, Bassiri H . American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 1. Arthritis Rheumatol. 2020; 72(11):1791-1805. PMC: 7405113. DOI: 10.1002/art.41454. View

Divithotawela C, Garrett P, Westall G, Bhaskar B, Tol M, Chambers D . Successful treatment of cytomegalovirus associated hemophagocytic lymphohistiocytosis with the interleukin 1 inhibitor - anakinra. Respirol Case Rep. 2016; 4(1):4-6. PMC: 4722096. DOI: 10.1002/rcr2.137. View

Aouba A, Baldolli A, Geffray L, Verdon R, Bergot E, Martin-Silva N . Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series. Ann Rheum Dis. 2020; 79(10):1381-1382. DOI: 10.1136/annrheumdis-2020-217706. View

Lu X, Zhang L, Du H, Zhang J, Li Y, Qu J . SARS-CoV-2 Infection in Children. N Engl J Med. 2020; 382(17):1663-1665. PMC: 7121177. DOI: 10.1056/NEJMc2005073. View

Bami S, Vagrecha A, Soberman D, Badawi M, Cannone D, Lipton J . The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2020; 67(11):e28581. DOI: 10.1002/pbc.28581. View

Huet T, Beaussier H, Voisin O, Jouveshomme S, Dauriat G, Lazareth I . Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol. 2020; 2(7):e393-e400. PMC: 7259909. DOI: 10.1016/S2665-9913(20)30164-8. View

Parisi F, Paglionico A, Varriano V, Ferraccioli G, Gremese E . Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: A case report treated with high doses (8 mg/kg/d) of anakinra. Medicine (Baltimore). 2017; 96(24):e6656. PMC: 5478301. DOI: 10.1097/MD.0000000000006656. View

Zhang C, Wu Z, Li J, Zhao H, Wang G . Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020; 55(5):105954. PMC: 7118634. DOI: 10.1016/j.ijantimicag.2020.105954. View

10.

Schulert G, Cron R . The genetics of macrophage activation syndrome. Genes Immun. 2020; 21(3):169-181. DOI: 10.1038/s41435-020-0098-4. View

11.

Kim S, Kissoon-Larkin T, Horn B, Elder M . Anakinra as an agent to control hemophagocytic lymphohistiocytosis in Griscelli type 2. Pediatr Blood Cancer. 2019; 66(12):e27997. DOI: 10.1002/pbc.27997. View

12.

Henter J, Horne A, Arico M, Egeler R, Filipovich A, Imashuku S . HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2006; 48(2):124-31. DOI: 10.1002/pbc.21039. View

13.

Eloseily E, Weiser P, Crayne C, Haines H, Mannion M, Stoll M . Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis. Arthritis Rheumatol. 2019; 72(2):326-334. DOI: 10.1002/art.41103. View

14.

Kahn P, Cron R . Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome. J Rheumatol. 2013; 40(5):743-4. DOI: 10.3899/jrheum.121098. View

15.

McGonagle D, Sharif K, ORegan A, Bridgewood C . The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev. 2020; 19(6):102537. PMC: 7195002. DOI: 10.1016/j.autrev.2020.102537. View

16.

Macartney C, Weitzman S, Wood S, Bansal D, Steele M, Meeths M . Unusual functional manifestations of a novel STX11 frameshift mutation in two infants with familial hemophagocytic lymphohistiocytosis type 4 (FHL4). Pediatr Blood Cancer. 2011; 56(4):654-7. DOI: 10.1002/pbc.22676. View

17.

Arico M, Danesino C, Pende D, Moretta L . Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol. 2001; 114(4):761-9. DOI: 10.1046/j.1365-2141.2001.02936.x. View

18.

Mehta P, McAuley D, Brown M, Sanchez E, Tattersall R, Manson J . COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395(10229):1033-1034. PMC: 7270045. DOI: 10.1016/S0140-6736(20)30628-0. View

19.

Bergsten E, Horne A, Arico M, Astigarraga I, Egeler R, Filipovich A . Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017; 130(25):2728-2738. PMC: 5785801. DOI: 10.1182/blood-2017-06-788349. View